HARE-40: HPV Anti-CD40 RNA vaccinE
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to BioNTech SE
Related studies linked through entity extraction aliases.
A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL.
- Status
- RECRUITING
- Phase
- PHASE1
Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID
- Status
- COMPLETED
- Phase
- PHASE1
GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients
- Status
- COMPLETED
- Phase
- PHASE1